4//SEC Filing
Terrillion Scott 4
Accession 0001415889-24-002536
CIK 0001346830other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:34 PM ET
Size
5.3 KB
Accession
0001415889-24-002536
Insider Transaction Report
Form 4
Terrillion Scott
SEC'Y; CHIEF COMPLIANCE & G.C.
Transactions
- Award
Common Stock
2024-02-01+13,500→ 102,063 total
Footnotes (1)
- [F1]Represents the number of shares that vested under a performance-based restricted stock unit award (the "Award") granted on March 1, 2023 based on the Issuer's satisfaction of certain performance criteria of the Award. In light of the performance-based vesting conditions of the Award, such shares were not reportable under Section 16 until vesting was determined. On February 1, 2024, the Compensation Committee of the Issuer's Board of Directors certified a 50% level of achievement against the Award's performance goals.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001706426
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:34 PM ET
- Size
- 5.3 KB